Dermatol. praxi. 2015;9(1):45-46

Drug-induced lupus erythematosus

doc.MUDr.Světlana Brychtová, Ph.D.1, MUDr.Martin Tichý, Ph.D.2
1 Ústav klinické a molekulární patologie
2 Klinika chorob kožních a pohlavních, LF UP a FN Olomouc

A case of drug-induced lupus erythematosus in an 85-year-old woman is presented associated with treatment with the beta-blocker

bisoprolol. In terms of clinical and laboratory features, this disease completely mimics idiopathic SLE; however, it is usually more common

in elderly patients and affects men and women equally. The article places emphasis on the histological presentation and clinical-

-pathological correlation of the findings.

Keywords: lupus erythematosus, drug-induced adverse skin reactions, lichenoid dermatitis

Published: March 16, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Brychtová S, Tichý M. Drug-induced lupus erythematosus. Dermatol. praxi. 2015;9(1):45-46.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Wong NY, Parsons LM, Trotter MJ, Tsang RY. Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case report. BMC Res Notes. 2014; 7: 785. doi: 10.1186/1756-0500-7-785. Go to original source... Go to PubMed...
    2. Murie J, Agarwal M. Sub-acute cutaneous lupus erythematosus following nitrofurantoin: causative or coincidental? Scott Med J. 2014; 59(4): e21-25. doi: 10.1177/0036933014558000. Go to original source... Go to PubMed...
    3. Kwong HL, Teo RY. An uncommon cutaneous reaction for a common drug. Diagnosis: Drug-induced subacute cutaneous lupus erythematosus (DI-SCLE). Ann Acad Med Singapore. 2014; 43(8): 433-434. Go to original source...
    4. Vedove CD, Del Giglio M, Schena D, Girolomoni G. Drug-induced lupus erythematosus. Arch Dermatol Res. 2009; 301(1): 99-105. doi: 10.1007/s00403-008-0895-5. Go to original source... Go to PubMed...
    5. Vedove CD, Simon JC, Girolomoni G. Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNF? agents. J Dtsch Dermatol Ges. 2012; 10(12): 889-897. doi: 10.1111/j.1610-0387.2012.08000. Go to original source...
    6. Lowe GC, Henderson CL, Grau RH, Hansen CB, Sontheimer RD. A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2011; 164(3): 465-472. doi: 10.1111/j.1365-2133.2010.10110. Go to original source... Go to PubMed...
    7. Sandholdt LH, Laurinaviciene R, Bygum A. Proton pump inhibitor-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2014; 170(2): 342-351. doi: 10.1111/bjd.12699. Go to original source...
    8. Gubinelli E, Cocuroccia B, Girolomoni G. Subacute cutaneous lupus erythematosus induced by nifedipine. J Cutan Med Surg. 2003; 7(3): 243-246. Go to original source...
    9. Marzano AV, Tavecchio S, Menicanti C, Crosti C. Drug-induced lupus erythematosus. G Ital Dermatol Venereol. 2014; 149(3): 301-309.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.